期刊论文

中文

中国动脉硬化杂志

1007-3949

2000

8

1

64-66

10.3969/j.issn.1007-3949.2000.01.018

本校为第一机构

为探讨去非罗齐用药剂量与临床疗效之间的关系 ,将 12 1例原发性高脂血症患者随机分为低剂量组和常规剂量组 ,低剂量组患者用吉非罗齐 6 0 0mg/d治疗 ,常规剂量组患者用吉非罗齐 12 0 0mg/d治疗 ,观察两组患者服药前及服药 4周、8周血脂水平的变化。结果发现 ,服药 4周常规剂量组血清总胆固醇和甘油三酯下降 ,高密度脂蛋白胆固醇上升 ,与治疗前有非常显著性差异 (P

Aim [WT5”BZ]The present study was to compare the clinical efficacy of low dose gemfibrozil with normal dose gemfibrozil administered in hyperlipidemic patients. [WT5”HZ]Methods [WT5”BZ]121 subjects were randomized into two groups: 62 Subjects in low dose gemfribrozil group,59 subjects in normal dose gemfibrozil group as controls. Blood lipid levels were determined prior to lipid lowering treatment and at the end of 4th and 8th week treatment respectively. [WT5”HZ]Results [WT5”BZ] At the end of the 4th week treatment, levels of TC and TG in...